Diagnosis and treatment of primary Sjögren syndrome-associated peripheral neuropathy: a six-case series

REFERENCES

• Alexander EL, Malinow K, Lejewski JE. Primary Sjogren's syndrome with central nervous system disease mimicking mul-tiple sclerosis. Ann Intern Med. 1986;104:323–30.
   Google Scholar
• Rapoport P, Merle H, Smadja D, Gerard M, Alliot E. Bilateral optic neuropathy disclosing primary Gougerot-Sjogren syn-drome. J Fr Ophtalmol. 1997;20:767–70.
   Google Scholar
• Youinou Y. Sjogren's syndrome: a quintessential B cell-induced autoimmune disease. Joint Bone Spine. 2008;75:1–2.
   PubMedGoogle Scholar
• Hietahatju A, Yli-Kerttula U, Hlikkinen V, Frey H. Nervous system manifestations in Sjogren's syndrome. Acta Neurol Scand. 1990;81:144–52.
   PubMedGoogle Scholar
• Visser LH, Koudstaal PJ, Van De Merwe JP. Hemiparkinsonism in a patient with primary Sjogren's syndrome. A case report and a review of the literature. Clin Neurol Neurosurg. 1993;95:141–5.
   Google Scholar
• Gemignani F, Marbini A, Pavesi G, Di Vittorio S, Manganelli P, Cenacchi G, et al. Peripheral neuropathy associated with primary Sjogren's syndrome. J Neurol Neurosurg Psychiatry. 1994;57: 983–6.
   PubMed Web of Science ®Google Scholar
• Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, et al. Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine. 2004;83:280–91.
   PubMed Web of Science ®Google Scholar
• Fujibayashi T, Sugai S, Miyasaka N, Toujou T, Miyawaki S, Ichikawa Y, et al. Revised Japanese diagnostic criteria for Sjo-gren's syndrome. Annual Report of Research Committee for Immune Disease. Tokyo: Japanese Ministry of Health and Wel-fare; 1999. p. 135–8.
   Google Scholar
• Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alex-ander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.
   Google Scholar
• Harboe E, Tjensvoll AB, Maroni S, Goransson LG, Greve OJ, Beyer MK, et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjögren syndrome: a comparative population-based study. Ann Rheum Dis. 2009;68: 1541–6.
   PubMed Web of Science ®Google Scholar
• Skopouli FN, Dafni U, Ioannidis JP, Moutsopoulos HM. Clinical evolution, and morbidity and mortality of primary Sjogren's syndrome. Semin Arthritis Rheum. 2000;29:296–304.
   PubMed Web of Science ®Google Scholar
• Pavlakis PP, Alexopoulos H, Kosmidis ML, Mamali I, Moutso-poulos HM, Tzioufas AG, et al. Peripheral neuropathies in Sjö-gren's syndrome: a critical update on clinical features and pathogenetic mechanisms. J Autoimmun. 2012;39:27–33.
   Google Scholar
• Amoura Z, Lafitte C, Piette JC. Gougerot-Sjogren syndrome. Neurologic complications. Presse Med. 1999;28:1209e13.
   Google Scholar
• Mrabet D, Meddeb N, Ajlani H, et al. Cerebral vasculitis in a patient with rheumatoid arthritis. Joint Bone Spine. 2007;74: 201–4.
   PubMedGoogle Scholar
• Mellgren SI, Conn DL, Stevens JC, Dyck PJ. Peripheral neu-ropathy in primary Sjogren's syndrome. Neurology. 1989;39: 390–4.
   PubMed Web of Science ®Google Scholar
• Mori K, Iijima M, Koike H, Hattori N, Tanaka F, Watanabe H, et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain. 2005;128:2518.
   PubMed Web of Science ®Google Scholar
• Mori K, Koike H, Misu K, Hattori N, Ichimura M, Sobue G. Spinal cord magnetic resonance imaging demonstrates sensory neuronal involvement and clinical severity in neuronopathy associated with Sjogren's syndrome. J Neurol Neurosurg Psy-chiatry. 2001;71:488–92.
   PubMed Web of Science ®Google Scholar
• Chai J, Herrmann DN, Stanton M, Barbano RL, Logigian EL. Painful small-fiber neuropathy in Sjögren syndrome. Neurology. 2005;65:925.
   Google Scholar
• Font J, Ramos-Casals M, de la Red G, Pou A, Casanova A, Garcia-Canasco M, et al. Pure sensory neuropathy in primary Sjogren's syndrome. Long-term prospective follow-up and review of the literature. J Rheumatol. 2003;30:1552.
   Google Scholar
• Waterschoot MP, Guerit JM, Lambert M, de Barsy T. Bilateral tonic pupils and polyneuropathy in Sjogren's syndrome: a com-mon pathophysiological mechanism? Eur Neurol. 1991;31: 114–6.
   Google Scholar
• Moutsopoulos HM, Sarmas JH, Talal N. Is central nervous sys-tem involvement a systemic manifestation of primary Sjogren's syndrome? Rheum Dis Clin North Am. 1993;19:909.
   Google Scholar
• Alexander EL. Neurologic disease in Sjogren's syndrome: mononuclear inflammatory vasculopathy affecting central/ peripheral nervous system and muscle. A clinical review and update of immunopathogenesis. Rheum Dis Clin North Am. 1993;19:869.
   PubMedGoogle Scholar
• Alexander EL, Provost TT, Stevens MB, Alexander GE. Neuro-logic complications of primary Sjogren's syndrome. Medicine. 1982;61:247–57.
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Kinnunen E, Bonsdorff MV. Acute transverse myelopathy successfully treated with plasmapheresis and prednisone in a patient with primary Sjogren's syndrome. Arthritis Rheum. 1987;30:339–43.
   Google Scholar
• Williams CS, Butler E, Roman GC. Treatment of myelopathy in Sjögren syndrome with a combination of prednisone and cyclo-phosphamide. Arch Neurol. 2001;58: 815e9.
   Google Scholar
• Sobue G, Yasuda T, Kachi T, Sakakibara T, Mitsuma T. Chronic progressive sensory ataxic neuropathy: clinicopathological fea-tures of idiopathic and Sjogren's syndrome-associated cases. J Neurol. 1993;240:1–7.
   Google Scholar
• Grant IA, Hunder GG, Homburger HA, Dyck PJ. Peripheral neuropathy associated with sicca complex. Neurology. 1997;48: 855–62.
   PubMed Web of Science ®Google Scholar
• Mori K, Iijima M, Sugiura M, Koike H, Hattori N, Ito H, et al. Sjogren's syndrome associated painful sensory neuropathy without sensory ataxia. J Neurol Neurosurg Psychiatry. 2003;74: 1320–2.
   PubMed Web of Science ®Google Scholar
• Amoura Z, Lafitte C, Piette JC. Gougerot-Sjogren syndrome. Neurologic complications. Presse Med. 1999;28:1209–1.
   Google Scholar
• Alexander EL. Neurologic complications of Sjogren's syndrome. Rheum Dis Clin North Am. 1992;18:637–72.
   PubMedGoogle Scholar
• Takahashi Y, Takata T, Hoshino M, Sakurai M, Kanazawa I. Benefit of IVIG for long-standing ataxic sensory neuronopathy with Sjogren's syndrome, IV immunoglobulin. Neurology. 2003; 60:503.
   Google Scholar
• Morozumi S, Kawagashira Y, Iijima M, Koike H, Hattori N, Katsuno M, et al. Intravenous immunoglobulin treatment for painful sensory neuropathy associated with Sjogren's syndrome. J Neurol Sci. 2009;15(279):57–61.
   Google Scholar
• Thornton CA, Griggs RC. Plasma exchange and intravenous immunoglobulin treatment of neuromuscular disease. Ann Neu-rol. 1994;35:260–8.
   PubMedGoogle Scholar
• Hartung HP, Pollard JD, Harvey GK, Toyka KV. Immuno-pathogenesis and treatment of the Guillain-Bané syndrome-part II. Muscle Nerve. 1995;18:154–64.
   PubMedGoogle Scholar